Close Menu

NEW YORK (360Dx) – Qiagen said on Thursday that Japan's Ministry of Health, Labor and Welfare has approved QuantiFeron-TB Gold Plus (QFT-Plus) as an in vitro diagnostic to detect tuberculosis infection.

QFT-Plus is the fourth generation of Qiagen's QuantiFeron-TB technology, combining CD4+/CD8+ design for comprehensive immune response detection with a flexible blood collection workflow for efficient screening in large-scale TB control programs, Qiagen said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.